We present a noninvasive optical method to measure the oxygen saturation of hemoglobin in breast lesions. This method introduces the novel concept that the best choice of near-infrared wavelengths for noninvasive tumor oximetry consists of a wavelength pair ͑ 1 , 2 ͒ within the range 680 -880 nm, where the specific values of 1 and 2 depend on the optical properties of the specific tumor under examination. Our method involves two steps: ͑1͒ identify the optimal wavelength pair for each tumor and ͑2͒ measure the tumor oxygenation using the optical data at the two selected wavelengths. We have tested our method by acquiring experimental optical data from turbid media containing cylindrical or irregularly shaped inhomogeneities and by computing theoretical data for the case of spherical lesions embedded in a highly scattering medium. We have found that our optical method can provide accurate and quantitative measurements of the oxygenation of embedded lesions without requiring knowledge of their size, shape, and depth.
Introduction
Breast cancer is the most common cancer diagnosed and the second leading cause of cancer death among women in the United States. 1 The current method for screening is x-ray mammography, which provides high-resolution images but uses ionizing radiation, thus presenting the risk of inducing cancer. Furthermore, significant variations in interpreter performance have been observed that are due to the qualitative nature of the image analysis. 2 Other possible methods of breast cancer detection are computed tomography, which is used to detect abnormalities that are difficult to pinpoint with conventional mammography ͑i.e., in cases in which tumors are close to the chest wall͒; ultrasound, which is used to distinguish fluid-filled cysts from other types of lesion; and magnetic resonance imaging and positron emission tomography which are used to determine abnormally active tissues. 3 Magnetic resonance imaging and positron emission tomography are being studied as supplementary tests to x-ray mammography to distinguish benign from malignant lesions in high-risk patients. 4 In addition, thermography and immunodetection have been mentioned as additional detection modalities. [5] [6] [7] Optical techniques have been proposed for many years as an alternative breast imaging modality that provides a safe and noninvasive study of the human breast. The initial investigation of optical methods for detection of breast cancer began in 1929, when Cutler proposed transillumination of the breast with broad-beam continuous-wave ͑cw͒ light, 8 a technique for which the terms diaphanography 9 and light scanning 10 were later adopted. Eventually diaphanography and light scanning were abandoned after clinical studies reported inferior performance with respect to x-ray mammography. [11] [12] [13] Recently, however, technical advances and the application of diffusion theory to model the propagation of light in tissue 14 -20 have led to new approaches to optical mammography. As a result, new time-domain ͑based on pulsed light sources͒, [21] [22] [23] [24] [25] frequency-domain ͑based on intensitymodulated light sources͒, 26 -30 and cw methods [31] [32] [33] for the optical study of the human breast have emerged.
Optical imaging in the near infrared relies mainly on the absorption of hemoglobin for the source of image contrast. Hemodynamic changes such as an increase in the vascular density ͑resulting from angiogenesis͒ and changes in the blood flow and oxygenation typically occur at tumor sites. 34 The increase in vascular density induces a local increase in the optical absorption that may allow for the detection of breast lesions but does not necessarily provide indications on the nature ͑benign or malignant͒ of the lesion. The oxygenation level of the lesion, however, may provide this distinction. Measurements of the partial pressure of oxygen in tumors have shown that hypoxic or anoxic conditions often exist in malignant tumors but not in benign lesions. [35] [36] [37] [38] Therefore a measurement of the oxygenation level in vivo has the potential to distinguish benign from malignant lesions in the human breast. As a result of these findings, several groups have attempted to obtain measurements of tumor oxygen saturation. Zhu et al. have reported deoxyhemoglobin and oxyhemoglobin concentration differences between tumors and background tissue, but did not obtain quantitative assessments of oxygen saturation ͑SO 2 ͒. 39 Holboke et al. have reported tumor oxygen saturation measurements where ultrasound is used for localization and the optical methods are used purely for spectroscopic measurements. 40 In a measurement on a single patient, they found a value of tumor oxygenation ͑63%͒ significantly lower than the values measured in the surrounding tissue ͑73% and 68%͒. 40 Using a nonimaging method on relatively large ͑approximately 2 cm ϫ 1 cm͒ and superficial tumors, Tromberg et al. 41, 42 have also reported a lower hemoglobin oxygenation in tumor with respect to normal tissue ͓SO 2͑tumor͒ ϳ 65% and SO 2͑normal͒ ϳ 80%͔. McBride et al. have been able to obtain oxygen saturation measurements to within 15% of the actual values in phantoms and have reported similar oxygenation values in normal human breast tissue as found in the research of Tromberg et al. ͓SO 2͑normal͒ ϭ 84% Ϯ 11%͔. 43 Fantini et al. 44 have performed similar measurements in which oxygen saturation of a papillary cancer was measured to be 71% Ϯ 9%.
In this paper we present a novel spectral imaging approach that is aimed at quantifying the oxygen saturation of the hemoglobin in breast lesions. The strength of our new approach is its insensitivity to the tumor size, shape, and depth within the breast. We report experimental results on tissuelike phantoms and theoretical results for an idealized case that illustrate the capability of our method to provide accurate and quantitative oxygenation measurements of embedded tumors. The basic idea is that an appropriate choice of a pair of wavelengths ͑ 1 , 2 ͒, which depends on the oxygenation level of the tumor and on the optical properties of the background healthy breast tissue, leads to a measurement of the tumor oxygenation that is largely independent of the tumor size, shape, and location inside the breast. The fact that the best choice of wavelengths for the near-infrared measurement of tumor oxygenation is not fixed, but rather depends on the tumor oxygenation itself, is the most significant new concept introduced by our spectral imaging approach.
Methods

A. Mathematical Model
Our starting point is to treat the tumor as an optical perturbation within a highly scattering background medium ͑breast tissue͒. To a first approximation, a localized optical perturbation embedded in a turbid medium can be modeled with the first-order perturbative solution to the diffusion equation. First-order perturbation applies to small optical perturbations, where small means that the linear dimensions of the perturbation are much smaller than the distance r between the illumination and the collection points, that induce a small ͑with respect to 1͒ relative change in the optical signal. This case is schematically illustrated in Fig. 1 for a lesion embedded in a transilluminated human breast.
Let us denote the absorption and reduced scattering coefficient of the background medium ͑healthy breast tissue͒ with a0 and s0 Ј, respectively, and the absorption and scattering perturbations ͑associated with the tumor͒ with ⌬ a and ⌬ s Ј, respectively. This means that the absorption and reduced scattering coefficients at the location of the optical perturbation ͑tumor͒ are given by a0 ϩ ⌬ a and s0 Ј ϩ ⌬ s Ј, respectively. The relative intensity change ⌬I͞I 0 ͑where I 0 is the unperturbed intensity measured in the background medium͒ induced by the optical perturbation is maximized ͑in absolute value͒ when the source, detector, and the perturbation are collinear as shown in Fig. 1 . The first-order perturbative solution to the diffusion A small optical perturbation ͑lesion͒ causes a maximal reduction in intensity at the detector when the source, detector, and lesion are collinear. The distance from the center of the lesion to the detector is r 0 , and the source-detector separation is r. equation leads to the following expression for this maximal intensity change: 45 
⌬I
Here V is the volume of the lesion, and the geometric parameters r and r 0 are defined in Fig. 1 . The second term inside the braces in Eq. ͑1͒, the scattering perturbation term, is neglected on the basis of in vivo studies that have shown that the scattering tumor-tobackground contrast is much smaller than the absorption contrast. 24, 42, 44 Therefore Eq. ͑1͒ is reduced to
As shown by Eq. ͑2͒, first-order perturbation theory predicts that the maximal intensity effect of an optical inclusion ͑for the case ⌬ s Ј ϭ 0͒ is given by the product of a wavelength-independent geometric factor and a wavelength-dependent factor given by s0 Ј⌬ a . Chernomordik et al. have extended the limit of validity of Eq. ͑2͒ to larger inclusions by adding a multiplicative factor equal to exp͓Ϫ s0 Ј⌬ a V
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͞2͔ to the right-hand side of Eq. ͑2͒. 46 We now proceed on the hypothesis that Eq. ͑2͒ can be generalized to correctly predict the functional dependence of ⌬I͞I 0 ͉ max on a0 , s0 Ј, and ⌬ a beyond the limits of validity of the first-order perturbation analysis. Specifically, we hypothesize that, in the case of ⌬ s Ј ϭ 0, we can generalize Eq. ͑2͒ to the case of spatially extended objects that induce significant changes in the optical intensity by saying that ⌬I͞ I 0 ͉ max depends only on the product s0 Ј⌬ a and on wavelength-independent parameters that are related to the source-detector separation r and to the objectdetector distance r 0 , size V, and shape s of the object. Therefore we write
where f indicates an unknown function of its arguments. We further hypothesize that, as in the perturbation case, ⌬I͞I 0 ͉ max is a monotonic function of the product s0 Ј⌬ a . These two hypotheses are consistent with Eq. ͑2͒ and with its extension to larger inclusions reported by Chernomordik et al. 46 At this point, it is important to observe that the wavelength dependence of ⌬I͞I 0 ͉ max appears only implicitly in the argument s0 Ј⌬ a because the geometric parameters r, r 0 , V, and s are independent of the wavelength. Consequently, because of the monotonicity of ⌬I͞I 0 ͉ max on s0 Ј⌬ a , if two wavelengths 1 and 2 are such that ⌬I͞I 0 ͉ max
Therefore the ratio of the absorption perturbations at these two wavelengths is just given by the inverse of the ratio of the background reduced scattering coefficients at the same two wavelengths:
This analysis indicates that, by appropriately choosing the two wavelengths 1 and 2 , one can translate a measurement of the background scattering ratio into a measurement of the absorptionperturbation ratio associated with the embedded inclusion. This result is relevant for the nearinfrared determination of the oxygen saturation of hemoglobin in breast lesions because ͑1͒ the nearinfrared spectral properties of hemoglobin and breast tissue are such that it is usually possible to identify two wavelengths at which the tumorinduced intensity perturbations are similar and because ͑2͒ the oxygen saturation of hemoglobin is only a function of the ratio of the optical absorption at two wavelengths. 47 If the absorption at the tumor location is given by the sum of the contributions from the background ͑ a0 ͒ and from the tumor ͓ a ͑t͒ ͔, then ⌬ a can be identified with the tumor absorption ͓ a ͑t͒ ϭ ⌬ a ͔. If, instead, the absorption at the tumor location is due only to the tumor, then a ͑t͒ ϭ a0 ϩ ⌬ a . However, if ⌬ a Ͼ Ͼ a0 ͑high-contrast tumor͒, one can still argue that ⌬ a is representative of the tumor absorption ͓ a ͑t͒ Ϸ ⌬ a ͔. Here we consider the oxygen saturation ͑SO 2 ͒ of hemoglobin that is associated with the additional absorption ⌬ a . At least in the two cases mentioned above, SO 2 is representative of the tumor oxygenation. When we assume that ⌬ a is solely due to hemoglobin, the expression for SO 2 in terms of ⌬ a ͑ 1 ͒ and ⌬ a ͑ 2 ͒ is the following:
where ε Hb and ε HbO 2 are the molar extinction coefficients of deoxyhemoglobin and oxyhemoglobin, respectively.
In practice, it may not be possible to identify two wavelengths 1 and 2 that exactly satisfy the requirement that ⌬I͞I 0 ͉ max
In this case, we select the wavelength pair ͑ 1 , 2 ͒ that minimizes the absolute value of the difference ⌬I͞I 0 ͉ max
To correct, at least in part, for a difference between ⌬I͞I 0 ͉ max ͑ 1 ͒ and ⌬I͞I 0 ͉ max ͑ 2 ͒ , we assume, on the basis of Eq.
When we combine Eqs. ͑5͒ and ͑6͒, the lesion saturation is given by which is the equation we use to quantify the tumor oxygenation from measurements of ͑1͒ the background ͑healthy tissue͒ reduced scattering coefficient ͓ s0 Ј͔͑͒ and ͑2͒ the maximal relative change in the intensity caused by the tumor ͓⌬I͞I 0 ͉ max ͑͒ ͔. As a final comment on our mathematical model, we observe that, in addition to requiring that the intensity change induced by the inclusion is similar ͑ide-ally equal͒ at the two wavelengths, we also need to impose that these wavelengths are not too close to one another. In fact, Sevick et al. have shown that the sensitivity of the oxygenation measurement is degraded if the two near-infrared wavelengths are too close to each other. 48 In fact, a sensitivity analysis shows that lim 132 ‫⌬͑ץ‬ a 1 ͞⌬ a 2 ͒͞‫͑ץ‬SO 2 ͒ ϭ 0, because if 1 ϭ 2 , the ratio ⌬ a ͑ 1 ͒͞⌬ a ͑ 2 ͒ is equal to 1 independent of the value of SO 2 . It can also be shown that the sensitivity of near-infrared hemoglobin oximetry is higher if the two wavelengths 1 and 2 are on the opposite sides of the ϳ800-nm isosbestic point.
We adopt the criterion that ͉ 2 Ϫ 1 ͉ Ͼ 40 nm to guarantee that the minimization of the absolute value of the difference ⌬I͞I 0 ͉ max ͑ 1 ͒ Ϫ ⌬I͞I 0 ͉ max ͑ 2 ͒ yields an appropriate pair of wavelengths.
B. Experimental Procedures
The experimental portion of this study was divided into three segments: ͑1͒ preparation and optical characterization of inclusions to simulate tumors, ͑2͒ preparation and optical characterization of the background material ͑a highly scattering, liquid, effectively infinite medium͒, and ͑3͒ experimental procedures to investigate the dependence of ⌬I͞ I 0 ͉ max on s0 Ј⌬ a for the case of cylindrical and irregularly shaped objects embedded in a uniform turbid medium.
Optical Inclusions
Inclusions were comprised of a mixture of General Electric silicones, Model RTV615 ͑clear͒ and Model RTV11 ͑white͒. The white silicone was used as the scattering material, and black India ink was used as the absorber. Two different mixtures were prepared with different optical properties ͑the first with a ϳ 0.05-0.06 cm Ϫ1 and s Ј ϳ 9-10 cm Ϫ1 and the second with a ϳ 0.11-0.15 cm Ϫ1 and s Ј ϳ 9-10 cm Ϫ1 over the wavelength range of 752-840 nm considered here͒ to cover a range of ⌬ a that is representative of the expected absorption contrast of breast lesions in vivo. We performed the optical characterization of the inclusions using the arrangement shown in Fig.  2 . The silicone mixtures were formed into two cylindrically shaped blocks ͑one to characterize each mixture͒ of 11 cm in diameter and 9 cm in height. A frequency-domain, near-infrared spectrometer ͑Oxi-PlexTS, ISS, Inc., Champaign, Ill.͒ housed and controlled the laser sources and optical detectors used to obtain the measurements. The sources were laser diodes at six discrete wavelengths ͑752, 778, 786, 813, 830, and 840 nm͒, and the optical detector was a photomultiplier tube ͑Hamamatsu Photonics R928͒. The sources were intensity modulated at a frequency Fig. 2 . Experimental arrangement for the optical characterization of the material used to cast the optical inclusions. Each silicone mixture was formed into a cylindrically shaped block that is 11 cm in diameter and 9 cm in height. The initial sourcedetector separation was 1 cm. The detector fiber bundle remained stationary and was in contact with the surface of the block. The end of the source fiber bundle was placed close to the surface without touching ͑Ͻ0.25 mm͒ and was translated in the negative x direction at a rate of 0.65 mm͞s. Intensity and phase were acquired every 0.5 s. We determined the optical properties at six wavelengths ͑752, 778, 786, 813, 830, and 840 nm͒ using the diffusion model for light propagation in a semi-infinite medium.
of 110 MHz, electronically multiplexed at a rate of approximately 10 Hz to time share the detector, and were coupled to 400-m core-diameter optical fibers that were collected into a fiber bundle with a rectangular cross section of 1.2 mm in width and 3 mm in length. The detector was coupled to another fiber bundle of circular cross section ͑3-mm internal diameter͒. The detector fiber bundle remained fixed and was in contact with the surface of the silicone blocks, whereas the end of the source bundle was brought close to the surface of the blocks ͑Ͻ0.25 mm away͒. The starting distance between the source and the detector fibers was 1 cm ͑x direction͒. The source fiber was then moved in the negative x direction defined in Fig. 2 ͑away from the detector fiber͒ at a rate of 0.65 mm͞s. Data were acquired at every 0.5 s providing a measurement every 325 m over a total traveled distance of 2 cm. We recorded and translated the amplitude ͑ac͒, average value ͑dc͒, and phase of the detected modulated intensity into measurements of the reduced scattering and absorption coefficients by employing a multidistance method based on the diffusion equation and semi-infinite boundary conditions. 16 
Background Turbid Medium
The background medium was comprised of 1 liter of Liposyn 10% ͑Abbott Laboratories, North Chicago, Ill.͒ to 8 liters of deionized water and was contained in a rectangular vessel with dimensions of 27 cm in width, 32 cm in length, and 13 cm in height. Again, the ISS frequency-domain spectrometer was used to perform the measurements. The experimental arrangement was similar to that used in Fig. 2 except that the ends of the source and fiber bundles were fully immersed in the Liposyn mixture to simulate an infinite medium. Acquisition times, laser multiplexing rate, and source-displacement speed ͑with the detector remaining fixed͒ were also the same as in the inclusion characterization. The ac, dc, and phase data were used in the diffusion model for light propagation in an infinite, highly scattering medium to determine the background reduced scattering ͑ s0 Ј͒ and absorption coefficients ͑ a0 ͒. 
Optical Measurements of Inclusions Embedded in a Turbid Medium
The experimental procedure to investigate the dependence of ⌬I͞I 0 ͉ max on s0 Ј⌬ a was based on the arrangement shown in Fig. 3 . The ISS frequencydomain tissue spectrometer was employed at the same six wavelengths used above to determine the optical properties of the inclusion material and the background. In this arrangement, the source and detector fiber bundles were arranged collinearly, and their ends were fully immersed in the formerly characterized background medium to simulate an infinite geometry. The source-detector separation for these experiments remained a constant 6 cm, which is representative of the thickness of a slightly compressed breast. Inclusions of different sizes and shapes were then suspended in the medium equidistant from the source and detector by use of Pasteur pipets to hold them in place. The pipets were filled with a background medium to reduce the optical perturbation they might cause.
We formed the inclusion material into irregular shapes ͑by cutting cylindrical shapes with razor blades͒ and into a 10-cm-long cylinder using the two different mixtures, thus creating two different sets of the same sizes and shapes. The cylinder had a diameter of 1.0 cm, whereas the irregular shapes were created to have the same volumes as the spheres with a 0.9-cm diameter ͑V ϭ 0.43 cm 3 ͒ and a 1.4-cm diameter ͑V ϭ 1.31 cm 3 ͒, respectively. The source and detector optical fibers were scanned together over a 14-cm distance in the x direction ͑as shown in Fig. 3͒ beginning at a distance of approximately 7 cm from the center of the inclusion in the x direction. Scanning was performed at a rate of 0.65 mm͞s, and data were acquired every 0.88 s, providing a data point every 572 m. Fig. 3 . Experimental setup for the optical measurements of inclusions embedded in a turbid medium. Six laser diodes from the frequency-domain near-infrared spectrometer were coupled to the source fiber bundle, and the photomultiplier tube ͑PMT͒ was coupled to the detector fiber. The lasers were multiplexed ͑MUX͒ to time share the optical detector. The radio frequency ͑rf ͒ synthesizer provided the 110-MHz intensity modulation of the sources and the 110.005-MHz modulation of the PMT gain. The PMT output is low-pass filtered to isolate the downconverted 5-kHz frequency that is then digitally converted and processed. Source and detector fibers are arranged collinearly and are fully immersed in the Liposyn aqueous suspension. Source and detector separation was 6 cm and remained constant. The inclusions ͑either irregular or cylindrical͒ were suspended in the Liposyn mixture halfway between the source and the detector ͑inclusion center was 3 cm from the source and detector͒ by use of Pasteur pipets filled with the background medium. The source and detector were scanned together at a rate of 0.65 mm͞s over a total distance of 14 cm starting at 7 cm away from the center of the inclusion in the x direction. Optical data were acquired every 0.88 s during the scan.
C. Theoretical Computation of Optical Data for a Spherical Inclusion
We calculated the theoretical estimates of the optical signals using an analytical solution to the diffusion equation for a spherical inclusion embedded in an infinite turbid medium. 15 This solution was implemented in a photon migration imaging software package developed by Boas et al. at Massachusetts General Hospital, Charlestown, Mass., as part of publicly available software. 52 Two types of theoretical analysis were performed.
Our first analysis was aimed at testing the hypothesis that the dependence of ⌬I͞I 0 ͉ max on a0 , s0 Ј, and ⌬ a is well approximated by a function of the product s0 Ј⌬ a even outside of the perturbation regime as in the cases of spheres having a diameter that is not much smaller than the source-detector separation and for values of ⌬ a that are not much smaller than a0 . This means that ⌬I͞I 0 ͉ max , for the case of ⌬ s Ј ϭ 0 considered here, is independent of a0 and is not affected by s0 Ј and ⌬ a separately, but only by their product s0 Ј⌬ a . We carried out this theoretical analysis for two sphere diameters ͑1.4 and 3.0 cm͒ for the case in which the sphere is equidistant from the source and detector scanning lines ͑sphere center is 3.0 cm from either fiber in the collinear case͒. For the smaller sphere ͑1.4 cm in diameter͒, we also considered a 1.5-cm off-center position, where the distances from the sphere center to the source and detector fibers were 1.5 and 4.5 cm, respectively, in the collinear condition. Our second theoretical analysis was aimed at testing the effectiveness of our new method for the measurement of tumor oxygenation. In this analysis, we set the background absorption and scattering spectra a0 ͑͒ and s0 Ј͑͒, respectively, equal to typical absorption and reduced scattering spectra for breast tissue. We determined the absorption spectra by combining the absorption contributions from typical concentrations of oxyhemoglobin ͑ϳ4.4 M͒, deoxyhemoglobin ͑ϳ2.7 M͒, water ͑ϳ39.5% volume by volume͒, and lipids ͑ϳ60.5% volume by volume͒ in healthy breast tissue, as reported by Quaresima et al. 53 In the spectral region that we considered ͑680 -880 nm͒, a0 ranged from 0.023 cm Ϫ1 ͑at 680 nm͒ to 0.076 cm Ϫ1 ͑at 880 nm͒. The background-scattering spectrum was estimated from data reported by Cubeddu et al. on two healthy human subjects. 25 In the spectral region that we considered ͑680 -880 nm͒, s0 Ј ranged from 10.0 cm Ϫ1 ͑at 680 nm͒ to 7.8 cm Ϫ1 ͑at 880 nm͒. We then considered spherical lesions with no scattering contrast ͑⌬ s Ј ϭ 0͒ and with an absorption contrast provided by a hemoglobin concentration of 60 M ͑corresponding to ⌬ a ϭ 0.12 cm Ϫ1 at 800 nm͒. As in the first analysis, we considered two sphere diameters ͑1.4 and 3.0 cm͒ in the centered case ͑sphere halfway between the source and the detector scanning lines͒ and one sphere diameter ͑1.4 cm͒ in the off-center case ͑sphere 1.5-cm off center͒. The maximum relative change in the optical signal induced by the spherical lesion ͑⌬I͞ I 0 ͉ max ͒ was calculated at nine wavelengths ͑680, 720, 730, 758, 768, 776, 800, 840, and 880 nm͒ as a function of hemoglobin saturation values within the sphere over the range 0 -100%. This choice of wavelengths covered the 680 -880-nm diagnostic window and included the local maxima and minima in the deoxyhemoglobin absorption spectrum ͑730 and 758 nm, respectively͒ and the local minimum in the oxyhemoglobin absorption spectrum ͑680 nm͒. Table 1 shows the results of the measurements of the optical properties of the inclusions and background medium. The range of ⌬ a is from 0.014 to 0.12 cm Ϫ1 when we consider both silicone mixtures, whereas the range of ⌬ s Ј is from Ϫ0.5 to Ϫ2.9 cm
Results
A. Measurement of the Optical Properties of the Inclusions and Background Medium
Ϫ1
. Given the background optical properties of the order of 0.02 cm Ϫ1 for a0 and 9 cm Ϫ1 for s0 Ј, the absorption perturbations are approximately 70 -600% of the background absorption, whereas the scattering perturbations, in absolute value, do not exceed 31% of the background-reduced scattering coefficient. These conditions are representative of the range of optical contrast offered by tumors in the human breast in vivo. 24, 41, 42, 44 B. Experimental Measurements of ⌬I͞I 0 ͉ max for Cylindrical and Irregularly Shaped Inclusions Figure 4 shows a typical result of the optical intensity I measured during a linear scan across the object location at x ϭ 0. Because ⌬ a Ͼ 0, there is a decrease in detected intensity as the source-detector pair approaches the inclusion during the scan. The background value I 0 and the maximum ͑in absolute value͒ intensity change ͉⌬I͉ max are indicated in Fig. 4 . The spectrum of ͑⌬I͒ max ͞I 0 ͑͒ is then used by our method to guide the choice of the two wavelengths 1 and 2 that are used to measure the oxygenation of the embedded object according to Eq. ͑7͒.
The experimental results for Ϫ⌬I͞I 0 ͉ max as a function of the product s0 Ј⌬ a are reported in Fig. 5͑a͒ for the irregularly shaped inclusions and in Fig. 5͑b͒ for the cylindrical inclusion. In both cases, the fact that the experimental data of ⌬I͞I 0 ͉ max for a range of values of s0 Ј and ⌬ a ͑see Table 1͒ are distributed along a single curve as a function of the product s0 Ј⌬ a is indicative of the dependence of ⌬I͞I 0 ͉ max on s0 Ј⌬ a . In Figs. 5͑a͒ and 5͑b͒, the functions of s0 Ј⌬ a are represented by continuous curves. The deviations of the experimental points from the smooth lines are assigned to experimental errors and to the approximate fulfillment of the condition ⌬ s Ј ϭ 0 ͑see Table 1͒ . These experiments confirm our hypothesis that ⌬I͞I 0 ͉ max is only a function of the product s0 Ј⌬ a ͓as hypothesized in Eq. ͑3͔͒ even for objects with a relatively large size, cylindrical or irregular shape, and relatively high-absorption contrast. Furthermore, as also hypothesized, ⌬I͞I 0 ͉ max varies monotonically with s0 Ј⌬ a .
C. Theoretical Calculations of ⌬I͞I 0 ͉ max for Spherical Inclusions Figure 6͑a͒ shows the calculated dependence of Ϫ⌬I͞ I 0 ͉ max on the product s0 Ј⌬ a for a spherical object embedded in a uniform turbid medium. As described in Subsection 2.C, we considered two sphere diameters ͑1.4 and 3.0 cm͒ for the case in which the sphere is equidistant from the source and detector fibers and one sphere diameter ͑1.4 cm͒ for the offaxis case in which the sphere is 1.5 cm off the midline between the source and the detector. The absorption coefficient of the background medium ͑ a0 ͒ is 0.06 cm
, and the scattering perturbation ͑⌬ s Ј͒ is set to zero. In all three cases considered, we found that ⌬I͞I 0 ͉ max is not separately dependent on s0 Ј and ⌬ a , but it only depends, monotonically, on their product ͓see Fig. 6͑a͔͒. Furthermore, Fig. 6͑b͒ shows that ⌬I͞I 0 ͉ max is weakly dependent on a0 over the range of optical properties of interest.
D. Theoretical Test of the New Method to Measure the Oxygenation of Optical Inclusions
To test the effectiveness of our new method, we computed the values of Ϫ⌬I͞I 0 ͉ max at nine wavelengths ͑680, 720, 730, 758, 768, 776, 800, 840, and 880 nm͒ , and background-reduced scattering s0 Ј was 11.1 cm
Ϫ1
. The scan coordinate x ϭ 0 corresponds to the location of the center of the inclusion in the scan. The maximum intensity change ͉⌬I͉ max caused by the inclusion and the background intensity I 0 are indicated. for a spherical inclusion in a case that mimics a realistic condition in optical mammography. As described in Subsection 2.C, we set the background scattering and absorption spectra equal to representative spectra for healthy breast tissue obtained from literature data. 25, 53 We observe that, because of the results of Fig. 6͑b͒ , the background absorption spectrum plays a minor role in the determination of ⌬I͞ I 0 ͉ max . We set the hemoglobin concentration of the embedded lesion to a value 60 M higher than that in the background, and we varied the hemoglobin saturation of the sphere over the range 0 -100%. The resulting spectra of the product s0 Ј⌬ a for SO 2 values of 0, 20, 40, 60, 80, and 100% are reported in Fig.  7 , where we also indicate with dashed lines the wavelengths used in our calculations. On the basis of our key hypothesis ͓Eq. ͑3͔͒, the spectra of Fig. 7 are representative of the spectra of ⌬I͞I 0 ͉ max . We compared the measurements of the hemoglobin saturation in the lesion obtained ͑1͒ by using Eq. ͑5͒ and a ratio ⌬ a ͑ 2 ͒͞⌬ a ͑ 1 ͒ computed with the perturbation theory ͓Eq. ͑2͔͒ from the intensity change ⌬I͞ I 0 ͉ max measured at two fixed wavelengths and ͑2͒ by using our new method ͓Eq. ͑7͔͒ at two wavelengths that are at least 40 nm apart and that minimize the absolute value of the difference ⌬I͞I 0 ͉ max ͑ 2 ͒ Ϫ ⌬I͞ I 0 ͉ max ͑ 1 ͒. Both approaches require knowledge of the background-reduced scattering coefficient, which was known in our theoretical computations and which can be measured with time-resolved methods in a practical implementation to the human breast. The results of the perturbation analysis for a number of wavelength pairs are shown in Fig. 8͑a͒ for a 1.4-cm-diameter sphere ͑on the midline between the source and the detector͒, in Fig. 8͑c͒ for a 3 .0-cmdiameter sphere ͑on the midline between the source and the detector͒, and in Fig. 8͑e͒ for a 1.4-cmdiameter sphere off the midline by 1.5 cm. The results of our new method are shown in Fig. 8͑b͒ ͑sphere diameter of 1.4 cm, on the midline͒, Fig. 8͑d͒ ͑sphere diameter of 3.0 cm, on the midline͒, and Fig.  8͑f ͒ ͑sphere diameter of 1.4 cm, 1.5 cm off the midline͒. These results show that our new method can achieve accurate measurements of the oxygenation of spherical regions over the full range of oxygenation values and independent of the size and location of the sphere. The wavelength pairs that minimize the difference between ⌬I͞I 0 ͉ max ͑ 1 ͒ and ⌬I͞I 0 ͉ max ͑ 2 ͒ ͓which is the criterion used to select the particular wavelength pairs in Figs. 8͑b͒, 8͑d͒ , and 8͑f ͔͒ for the cases of SO 2 equal to 0, 20, 40, 60, 80, and 100% are indicated in Fig. 7 . We also computed SO 2 using all nine wavelengths ͓by fitting a linear combination of the oxyhemoglobin and deoxyhemoglobin extinction spectra to ⌬ a ͑ i ͒ from Eq. ͑2͔͒ ͑data not shown͒, and we found Fig. 6 . Dependence of Ϫ⌬I͞I 0 ͉ max versus ͑a͒ s0 Ј⌬ a and ͑b͒ a0 calculated by the diffusion theory for a spherical object in an infinite turbid medium. In ͑a͒ a0 ϭ 0.06 cm
; in ͑b͒ s0 Ј⌬ a ϭ 1.5 cm
; in both ͑a͒ and ͑b͒ ⌬ s Ј ϭ 0. Two sphere diameters d were considered ͑1.4 and 3.0 cm͒ for the case in which the sphere is centered between the source and the detector, and one sphere diameter ͑1.4 cm͒ was considered for the case in which the sphere is 1.5 cm off center ͑uncentered case͒. The volume V of the spheres was also indicated-the open ͑closed͒ symbols in ͑a͒ refer to constant values of s0 Ј͑⌬ a ͒. and ⌬I͞I 0 ͉ max ͑2͒ ͑which is the criterion used in our method to select the particular wavelength pair͒ for each value of SO 2 . Fig. 8 . Calculations of the oxygen saturation ͑SO 2 ͒ of spherical inclusions versus their actual value ͓SO 2 ͑actual͒ ͔ used to compute the optical data from diffusion theory. ͑a͒, ͑c͒, and ͑e͒ show the perturbation approximation method when two fixed wavelengths were used to calculate SO 2 . ͑b͒, ͑d͒, and ͑f ͒ use the new method, which uses appropriately chosen wavelength pairs to determine SO 2 . ͑a͒ and ͑b͒ are calculations for a centered 1.4-cm-diameter sphere; ͑c͒ and ͑d͒ are calculations for a centered 3.0-cm-diameter sphere; and ͑e͒ and ͑f ͒ are calculations for an uncentered ͑1.5-cm off center͒ 1.4-cm-diameter sphere. The criterion to choose the most appropriate wavelength pair from the measured optical intensity is given in the text ͑Subsection 2.A͒.
no improvement on the fixed-wavelength pair results of Figs. 8͑a͒, 8͑c͒, and 8͑e͒. 
Discussion
We used first-order perturbation theory as a guide to develop our new method. In fact, our major hypothesis ͑namely, that in the case ⌬ s Ј ϭ 0, the ratio ⌬I͞I 0 ͉ max depends only on wavelength through the product s0 Ј⌬ a ͒ is suggested by the proportionality between ⌬I͞I 0 ͉ max ͑pert͒ and s0 Ј⌬ a found in the perturbation limit ͓see Eq. ͑2͔͒. Furthermore, the expression for the ratio ⌬ a ͑ 2 ͒͞⌬ a ͑ 1 ͒ ͓Eq. ͑6͔͒ that we use to compute the tumor saturation according to Eq. ͑5͒ is the same as the one provided by first-order perturbation theory ͓Eq. ͑2͔͒. Therefore it may appear that our approach is exclusively based on first-order perturbation theory. This is not the case because one key feature of our new method, namely, the criterion to select the two wavelengths 1 and 2 , is based on the results of Fig. 6 , which refer to situations that are beyond the limits of applicability of first-order perturbation theory. As a result, even if ⌬I͞I 0 ͉ max does not show a linear dependence on s0 Ј⌬ a as predicted by first-order perturbation theory, our method still provides accurate readings of the tumor saturation, provided that one can identify two wavelengths 1 and 2 such that ⌬I͞I 0 ͉ max ͒, even though the size of the inclusion also affects the extent of the quasi-proportionality range. In summary, the success of our method depends on the fulfillment of at least one of the three following conditions:
1. relatively small tumors; 2. relatively small tumor background absorption contrast; or 3. identification of two wavelengths, at least 40 nm apart, such that ⌬I͞I 0 ͉ max
The fulfillment of conditions 1 and 2 allows the applicability of the perturbative relationship given in Eq. ͑2͒, whereas the fulfillment of condition 3 enables the application of Eq. ͑7͒ on the basis of Eq. ͑3͒. In general, if condition 3 above cannot be fulfilled, the most accurate measurement of SO 2 will come from the wavelengths where the optical signal is least affected by the tumor, i.e., for the wavelengths at which the absolute value of ⌬I͞I 0 ͉ max is the smallest. The idea behind the development of our new method is that a robust approach to the optical oximetry of breast cancers will improve the diagnostic value of optical mammography. Instead of trying to obtain a full solution of the inverse imaging problem to determine the size, shape, location, and optical properties of the tumor, we aim at measuring one physiological parameter, namely, the tumor oxygenation, using a method that is insensitive to the size, shape, and location of the tumor. The insensitivity to the shape of the inclusion is shown by the experimental results of Fig. 5 , whereas the insensitivity to the size and location of the inclusion is shown by the theoretical results of Figs. 6 and 8. This approach has the potential of being more robust in practical clinical measurements with respect to full reconstruction schemes. The only information required by our method is ͑1͒ the spectrum of the backgroundscattering coefficient s0 Ј͑͒, ͑2͒ the background intensity I 0 ͑͒, and ͑3͒ the maximum intensity change ͑⌬I͒ max caused by the tumor. To best apply our method, the spectral measurements should be conducted at a large number of wavelengths in the range 680 -880 nm, possibly continuously over this spectral band.
In view of the actual implementation of this new method to clinical optical mammography, it is worth commenting on the required measurements of s0 Ј͑͒ and I 0 ͑͒. What is really required by our method is the ratio s0 Ј͑ 1 ͒͞ s0 Ј͑ 2 ͒ so that the spectral shape of s0 Ј, rather than its absolute value, is the critical quantity. This fact minimizes the influence of tissue inhomogeneity because it has been reported that the spectral shape of s0 Ј, but not its absolute value, is relatively constant at different breast locations. 25 As a result, s0 Ј͑͒ can be measured when timeresolved measurements are averaged at several breast locations. Because of the featureless scattering spectrum, measurements at a few discrete wavelengths i can be effectively extrapolated to yield a continuous spectrum of s0 Ј͑͒, as demonstrated by Bevilacqua et al. 54 With respect to the measurement of the background intensity I 0 ͑͒, in the presence of a heterogeneous background such as breast tissue, it may be appropriate to consider an average background intensity over a specifically selected breast area rather than the intensity measured at a particular breast location.
Our method is expected to be insensitive to boundary conditions. In fact, it has been reported that measurements based on comparing or ratioing data at two wavelengths ͓our method is based on a condition that involves the ratios ⌬I͞I 0 ͉ max ͑ 1 ͒ and ⌬I͞I 0 ͉ max ͑ 2 ͒ to assess the ratio ⌬ a ͑ 1 ͒͞⌬ a ͑ 2 ͔͒ are highly insensitive to boundary conditions. 55, 56 For this reason, we believe that the experimental and theoretical results presented here, which we obtained using effectively infinite media, are applicable to the bounded breast case of Fig. 1 .
The new method that we present in this paper is aimed at quantifying the oxygen saturation associated with ⌬ a , i.e., with the additional absorption at the tumor location with respect to the background tissue ͓see Eq. ͑5͔͒. We have argued that ⌬ a is indeed representative of the tumor absorption ͓ a ͑t͒ ͔ if ͑1͒ the absorption at the tumor location results from the sum of the background ͑healthy tissue͒ absorption ͑ a0 ͒ plus the tumor contribution ͓ a ͑t͒ ϵ ⌬ a ͔ or if ͑2͒ the tumor absorption a ͑t͒ is equal to a0 ϩ ⌬ a and ⌬ a Ͼ Ͼ a0 ͑high-contrast tumor͒. For the case in which a ͑t͒ ϭ a0 ϩ ⌬ a , but ⌬ a is not much greater than a0 , the tumor saturation SO 2 ͑t͒ may not be accurately represented by SO 2 of Eq. ͑5͒. In this case, the tumor saturation is given by where R ϭ ⌬ a ͑ 2 ͒͞⌬ a ͑ 1 ͒ is the ratio used in our method to calculate SO 2 . Because R is of the order of s0 Ј͑ 1 ͒͞ s0 Ј͑ 2 ͒, it is typically close to 1. As expected, SO 2 ͑t͒ given by Eq. ͑8͒ tends to the background saturation ͓SO 2
͑0͒
͔ in the limit ⌬ a 3 0 and to the saturation based on ⌬ a ͑SO 2 ͒ in the limit ⌬ a Ͼ Ͼ a0 . The derivative of SO 2 ͑t͒ with respect to ⌬ a ͑ 1 ͒ at constant R is given by Equation ͑9͒ shows that, for any given value of R, the sign of the derivative of SO 2 ͑t͒ with respect to ⌬ a ͑ 1 ͒ is independent of ⌬ a ͑ 1 ͒. As a result, SO 2 ͑t͒ monotonically increases ͑or decreases͒ from SO 2 ͑0͒ to SO 2 as the tumor contrast increases. This is graphically shown in Fig. 9 , which indicates whether the tumor is more oxygenated or less oxygenated than the background healthy tissue, is accurately given by the sign of SO 2 Ϫ SO 2 ͑0͒ independent of the tumor contrast. Furthermore, Fig. 9 indicates that, for ⌬ a Ͼ 0.1 cm Ϫ1 and tumor saturation values greater than 40%, SO 2 ͑t͒ and SO 2 differ by no more than ϳ5%. An estimate of ⌬ a ͑ 1 ͒, for example, on the basis of Eq. ͑2͒, may lead to a refinement of the tumor saturation measurement from the values of SO 2 ͑with our new method͒ and SO 2 ͑0͒ ͑mea-surable on healthy breast tissue͒. We conclude by stressing that this latter discussion based on Eqs. ͑8͒ and ͑9͒ pertains only to the cases in which the tumor absorption is better represented by a0 ϩ ⌬ a then by ⌬ a . If a ͑t͒ Ϸ ⌬ a , then SO 2 provides an accurate measurement of the tumor saturation.
Conclusion
We have presented a novel optical method to quantitatively measure the oxygen saturation of breast tumors. In the field of optical mammography, the most appropriate number of wavelengths to be used and the choice of those wavelengths are commonly questioned. According to our method, the optimal number of wavelengths to measure the tumor oxygenation is two ͑within the range 680 -880 nm͒, but the two specific wavelengths depend on the particular value of the tumor oxygenation. Therefore our method requires the collection of optical data at multiple wavelengths, ideally a continuum, and then selection of the two optimal near-infrared wavelengths for each tumor on the basis of a specific criterion ͓namely, the minimization of the absolute value of the difference ⌬I͞I 0 ͉ max ͑ 2 ͒ Ϫ ⌬I͞I 0 ͉ max ͑ 1 ͔͒. After the optimal wavelength pair has been selected, our Fig. 9 . Schematic for the case in which the tumor absorption is better represented by a0 ϩ ⌬ a then by ⌬ a and showing the dependence of the tumor saturation ͓SO 2 ͑t͒ ͔ on ⌬ a ͑ 1 ͒ for a background saturation SO 2 ͑0͒ ϭ 70% and six different values ͑0, 20, 40, 60, 80, 100%͒ of SO 2 . SO 2 is the saturation based on ⌬ a ͑ 1 ͒ and ⌬ a ͑ 2 ͒ that is provided by our new method. For each value of SO 2 , we considered the corresponding optimal wavelength pair that is given in Figs. 7 (9) method describes the way to process the optical data at these two wavelengths to obtain the tumor oxygenation. From laboratory experiments and theoretical calculations, we have found that we can accurately measure the oxygenation of embedded lesions over the full range 0 -100% independently of their size, shape, and depth. This method offers the potential to improve the diagnostic capability of optical mammography. We conclude by observing that, even if we have described an application to the oximetry of breast tumors, our method lends itself to measuring the oxygenation of other hemoglobin-rich localized tissue areas as well. For example, the focal increase in cerebral hemoglobin concentration induced by selected cerebral activity, a localized hematoma, or relatively large blood vessels can be investigated by some of the basic ideas presented here to measure their oxygenation levels.
We thank Maria Angela Franceschini for her help in the collection of the experimental data and David Boas for providing us with an updated version of the photon migration imaging software and for the critical reading of the manuscript. This research is sponsored by the U.S. Department of the Army, award DAMD17-99-1-9218. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, Md. 21702-5014, is the awarding and administering acquisition office. This research is also supported in part by the National Science Foundation, award BES-0093840.
